BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

201 related articles for article (PubMed ID: 28192398)

  • 21. Phosphatases and kinases regulating CDC25 activity in the cell cycle: clinical implications of CDC25 overexpression and potential treatment strategies.
    Sur S; Agrawal DK
    Mol Cell Biochem; 2016 May; 416(1-2):33-46. PubMed ID: 27038604
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Human Cdc25A phosphatase has a non-redundant function in G2 phase by activating Cyclin A-dependent kinases.
    Timofeev O; Cizmecioglu O; Hu E; Orlik T; Hoffmann I
    FEBS Lett; 2009 Feb; 583(4):841-7. PubMed ID: 19192479
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Activation of CDC25A phosphatase is limited by CDK2/cyclin A-mediated feedback inhibition.
    Ditano JP; Sakurikar N; Eastman A
    Cell Cycle; 2021 Jul; 20(13):1308-1319. PubMed ID: 34156324
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Stress-mediated exit to quiescence restricted by increasing persistence in CDK4/6 activation.
    Yang HW; Cappell SD; Jaimovich A; Liu C; Chung M; Daigh LH; Pack LR; Fan Y; Regot S; Covert M; Meyer T
    Elife; 2020 Apr; 9():. PubMed ID: 32255427
    [TBL] [Abstract][Full Text] [Related]  

  • 25. CDC25A pathway toward tumorigenesis: Molecular targets of CDC25A in cell-cycle regulation.
    Sadeghi H; Golalipour M; Yamchi A; Farazmandfar T; Shahbazi M
    J Cell Biochem; 2019 Mar; 120(3):2919-2928. PubMed ID: 30443958
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Arsenite slows S phase progression via inhibition of cdc25A dual specificity phosphatase gene transcription.
    Lehmann GM; McCabe MJ
    Toxicol Sci; 2007 Sep; 99(1):70-8. PubMed ID: 17545210
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Ubiquitin hydrolase Dub3 promotes oncogenic transformation by stabilizing Cdc25A.
    Pereg Y; Liu BY; O'Rourke KM; Sagolla M; Dey A; Komuves L; French DM; Dixit VM
    Nat Cell Biol; 2010 Apr; 12(4):400-6. PubMed ID: 20228808
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Malnutrition suppresses cell cycle progression of hematopoietic progenitor cells in mice via cyclin D1 down-regulation.
    Nakajima K; Crisma AR; Silva GB; Rogero MM; Fock RA; Borelli P
    Nutrition; 2014 Jan; 30(1):82-9. PubMed ID: 24290603
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A systematic screen for CDK4/6 substrates links FOXM1 phosphorylation to senescence suppression in cancer cells.
    Anders L; Ke N; Hydbring P; Choi YJ; Widlund HR; Chick JM; Zhai H; Vidal M; Gygi SP; Braun P; Sicinski P
    Cancer Cell; 2011 Nov; 20(5):620-34. PubMed ID: 22094256
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Cyclin A-CDK1 suppresses the expression of the CDK1 activator CDC25A to safeguard timely mitotic entry.
    Ng LY; Ma HT; Poon RYC
    J Biol Chem; 2023 Mar; 299(3):102957. PubMed ID: 36717077
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Androgen Receptor-Mediated Growth Suppression of HPr-1AR and PC3-Lenti-AR Prostate Epithelial Cells.
    Kim YC; Chen C; Bolton EC
    PLoS One; 2015; 10(9):e0138286. PubMed ID: 26372468
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Involvement of Cdc25A phosphatase in Hep3B hepatoma cell growth inhibition induced by novel K vitamin analogs.
    Wang Z; Southwick EC; Wang M; Kar S; Rosi KS; Wilcox CS; Lazo JS; Carr BI
    Cancer Res; 2001 Oct; 61(19):7211-6. PubMed ID: 11585757
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Differential effects of two growth inhibitory K vitamin analogs on cell cycle regulating proteins in human hepatoma cells.
    Markovits J; Wang Z; Carr BI; Sun TP; Mintz P; Le Bret M; Wu CW; Wu FY
    Life Sci; 2003 May; 72(24):2769-84. PubMed ID: 12679193
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The role of Cdc25A in the regulation of cell proliferation and apoptosis.
    Shen T; Huang S
    Anticancer Agents Med Chem; 2012 Jul; 12(6):631-9. PubMed ID: 22263797
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A novel CDC25A/DYRK2 regulatory switch modulates cell cycle and survival.
    Lara-Chica M; Correa-Sáez A; Jiménez-Izquierdo R; Garrido-Rodríguez M; Ponce FJ; Moreno R; Morrison K; Di Vona C; Arató K; Jiménez-Jiménez C; Morrugares R; Schmitz ML; de la Luna S; de la Vega L; Calzado MA
    Cell Death Differ; 2022 Jan; 29(1):105-117. PubMed ID: 34363019
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Mutually exclusive cyclin-dependent kinase 4/cyclin D1 and cyclin-dependent kinase 6/cyclin D2 pairing inactivates retinoblastoma protein and promotes cell cycle dysregulation in multiple myeloma.
    Ely S; Di Liberto M; Niesvizky R; Baughn LB; Cho HJ; Hatada EN; Knowles DM; Lane J; Chen-Kiang S
    Cancer Res; 2005 Dec; 65(24):11345-53. PubMed ID: 16357141
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A rate limiting function of cdc25A for S phase entry inversely correlates with tyrosine dephosphorylation of Cdk2.
    Sexl V; Diehl JA; Sherr CJ; Ashmun R; Beach D; Roussel MF
    Oncogene; 1999 Jan; 18(3):573-82. PubMed ID: 9989807
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Human Cdc14A phosphatase modulates the G2/M transition through Cdc25A and Cdc25B.
    Vázquez-Novelle MD; Mailand N; Ovejero S; Bueno A; Sacristán MP
    J Biol Chem; 2010 Dec; 285(52):40544-53. PubMed ID: 20956543
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Regulation of G(2)/M events by Cdc25A through phosphorylation-dependent modulation of its stability.
    Mailand N; Podtelejnikov AV; Groth A; Mann M; Bartek J; Lukas J
    EMBO J; 2002 Nov; 21(21):5911-20. PubMed ID: 12411508
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Potassium-induced apoptosis in rat cerebellar granule cells involves cell-cycle blockade at the G1/S transition.
    Martín-Romero FJ; Santiago-Josefat B; Correa-Bordes J; Gutierrez-Merino C; Fernandez-Salguero P
    J Mol Neurosci; 2000 Dec; 15(3):155-65. PubMed ID: 11303780
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.